The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
Tag: Clinical Trials
-
Alzheimer’s Drug Slows Cognitive Decline in Key Study
Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
-
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertain
An injection every two months rather than a daily pill could shield many more women from the virus, but it is unavailable in places that need it most.
-
Monkeypox Appears to Recede, but Risks and Uncertainties Linger
Scientists do not yet know how well the vaccine and the drug used to treat the infection are working. Two new trials will provide answers.